Summary of the practice guideline 'Hypertension' (third revision) from the Dutch College of General Practitioners;Samenvatting van de standaard 'Hypertensie' (derde herziening) van het Nederlands Huisartsen Genootschap

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 19, 2004, Pages 923-931

  Wiersma, T J ^a   Walma, E P ^a   Thomas, S ^a   Assendelft, W J J ^a  

^a DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DRUG INDICATION; GENERAL PRACTITIONER; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; NETHERLANDS; PRACTICE GUIDELINE; REVIEW; SCREENING; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; MASS SCREENING; PHYSICIANS, FAMILY; RISK FACTORS;

EID: 2942538108     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Walma EP, Thomas S, Prins A, Grundmeyer HG, Laan JR van der, Wiersma Ti. NHG-standaard Hypertensie. 3e herziening. Huisarts Wet 2003;46:435-49.
2. Kwaliteitsinstituut voor de Gezondheidszorg CBO (CBO). Herziening Richtlijn Hoge bloeddruk. Utrecht: CBO; 2000.
3. Grobbee DE, Tuut MK, Hoes AW. CBO-richtlijn 'Hoge bloeddruk' (herziening), Ned Tijdschr Geneeskd 2001;145:2071-6.
4. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
5. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 1994;272:1932-8.
6. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993;15:967-78.
7. Pearce KA, Furberg CD, Rushing J. Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials. Arch Fam Med 1995;4:943-50.
8. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002;162:577-81.
9. Deedwania PC. The changing face of hypertension: is systolic blood pressure the final answer? Arch Intern Med 2002;162:506-8.
10. Wright JM. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? I: Thiazide diuretics. CMAJ 2000;163:57-60.
11. Wright JM. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers. CMAJ 2000;163:188-92.
12. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279:1903-7.
13. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
14. Appel LJ. The verdict from ALLHAT- thiazide diuretics are the preferred initial therapy for hypertension. JAMA 2002;288:3039-42.
15. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356:1955-64.
16. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
17. Rutten GEHM, Verhoeven S, Heine RJ, Grauw WJC de, Cromme PVM, Reenders K, et al. Diabetes mellitus type 2. Huisarts Wet 1999;42:67-84.
18. Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing (CBO). Behandeling en preventie van coronaire hartziekten door verlaging van de plasmacholesterolconcentratie. Consensus cholesterol tweede herziening. Utrecht: CBO; 1998.
19. Thomas S, Weijden T van der, Drenth BB van, Haverkort AFM, Hooi JD, Laan JR van der. NHG-standaard Cholesterol (eerste herziening). Huisarts Wet 1999;42:406-17.
20. Laan JR van der, Thomas S. Samenvatting van de standaard 'Cholesterol' (eerste herziening) van het Nederlands Huisartsen Genootschap. Ned Tijdschr Geneeskd 2000;144:421-7.